Dextromethorphan and guaifenesin use need to be monitored thoroughly in people with "inadequate metabolizer" CYP2D6 enzyme concentrations and patients that are sedated. This mix medication includes a massive median toxic dose (TD50) to median productive dose (ED50) ratio (or therapeutic index) in these clients. Dextromethorphan and guaifenesin can result in https://vannevarx009lbp5.life-wiki.com/user